Cogent Biosciences (COGT) Insider Trading & Ownership $8.19 -0.07 (-0.85%) (As of 12/17/2024 05:30 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Cogent Biosciences (NASDAQ:COGT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.92%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$19.50 MNumber OfInsiders Selling(Last 3 Years)0 Get COGT Insider Trade Alerts Want to know when executives and insiders are buying or selling Cogent Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address COGT Insider Buying and Selling by Quarter Ad Porter & CompanyA conspiracy Trump won’t unsealNew documentary reveals the lost wealth-building secret hidden deep within ancient religious texts from almost every civilization… an investment one expert says is “so perfect that only God could have created it.” Watch it now to discover how this asset that you’ve likely never considered before can produce returns so safe, secure, and endless it is nothing short of miraculous.This is the untold, true story of God’s Investment. Cogent Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/9/2023Fairmount Funds Management LlcMajor ShareholderBuy800,000$12.00$9,600,000.00 6/16/2022Fairmount Funds Management LlcMajor ShareholderBuy1,200,000$8.25$9,900,000.00 (Data available from 1/1/2013 forward) COGT Insider Trading Activity - Frequently Asked Questions Who is on Cogent Biosciences's Insider Roster? The list of insiders at Cogent Biosciences includes Fairmount Funds Management Llc. Learn more on insiders at COGT. What percentage of Cogent Biosciences stock is owned by insiders? 5.92% of Cogent Biosciences stock is owned by insiders. Learn more on COGT's insider holdings. Which Cogent Biosciences insiders have been buying company stock? The following insider purchased COGT shares in the last 24 months: Fairmount Funds Management Llc ($9,600,000.00). How much insider buying is happening at Cogent Biosciences? Insiders have purchased a total of 800,000 COGT shares in the last 24 months for a total of $9,600,000.00 bought. Cogent Biosciences Key ExecutivesMr. Andrew R. Robbins M.B.A. (Age 48)President, CEO & Director Compensation: $1.06MDr. John Edward Robinson Ph.D. (Age 49)Chief Scientific Officer Compensation: $749.89kDr. Jessica Sachs M.D. (Age 49)Chief Medical Officer Compensation: $773.92kMr. John L. Green C.A. (Age 44)CPA, CFO & Principal Accounting Officer Compensation: $763.99kMr. Brad BarnettChief Technology OfficerChristi WaarichSenior Director of Investor RelationsMr. Evan D. Kearns J.D. (Age 44)Chief Legal Officer & Corporate Secretary Ms. Erin SchellhammerChief People OfficerMr. Dana R. Martin Pharm.D.Senior VP of Medical Affairs & Chief Patient OfficerBrad FellSenior Vice President of Chemistry More Insider Trading Tools from MarketBeat Related Companies PTC Therapeutics Insider Selling Verona Pharma Insider Selling Rhythm Pharmaceuticals Insider Selling MoonLake Immunotherapeutics Insider Selling Edgewise Therapeutics Insider Selling Janux Therapeutics Insider Selling Xenon Pharmaceuticals Insider Selling Merus Insider Selling ACADIA Pharmaceuticals Insider Selling Twist Bioscience Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:COGT) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cogent Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cogent Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.